Frontotemporal Dementia
📧 Sign up to get email alerts when something new happens for Frontotemporal Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-21Clinical Trial Update: Predict to Prevent PGRN Disease [NA]
A clinical trial investigating GRN-related frontotemporal dementia has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: ALS Research Collaborative
ALS Therapy Development Institute provides a clinical trial update for an ALS research collaboration, and the study is currently recruiting …
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
This clinical trial seeks to discover and validate protein structural complexes in circulating biofluids as biomarkers for early diagnosis, …
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
This clinical trial update describes a saliva-based Raman spectroscopy method to differentiate among several high-impact neurodegenerative d…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: IL-2 Plus Abatacept in FTD [Phase 1]
A Phase 1 clinical trial at The Methodist Hospital Research Institute is evaluating the combination of interleukin-2 and abatacept for front…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers [NA]
A completed clinical trial evaluating Kinto Care Coaching for dementia family caregivers with results posted. The study encompassed dementia…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias [NA]
This clinical trial update describes a study on molecular neuroimaging of neuroinflammation in neurodegenerative dementias that is currently…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Investigating Genetic Status in Patients Presenting to Clinic
A clinical trial at multiple centers is recruiting to study the genetic status of patients presenting with dementia syndromes, including fro…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: NYSCF Scientific Discovery Biobank
Clinical trial entry for the NYSCF Scientific Discovery Biobank (NCT06203106) shows recruiting status and lists indications including amyotr…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial [Phase 4]
This clinical trial update notes a Phase 4 N-of-1 study evaluating lemborexant for insomnia in a patient with dementia, with recruitment ong…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias [NA]
This clinical trial update notes that IRCCS San Raffaele is enrolling by invitation in a study using advanced electroencephalographic data a…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Telehealth-enabled Integrated Palliative Care for People With Dementia [NA]
A completed clinical trial evaluating telehealth-enabled integrated palliative care for people with dementia, sponsored by Thomas Jefferson …
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach
This study investigates genetic and environmental factors in the amyotrophic lateral sclerosis and frontotemporal dementia spectrum using a …
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia [Phase 2]
A Phase 2 trial evaluating low-dose lithium for behavioral symptoms in frontotemporal dementia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: tDCS Intervention in Primary Progressive Aphasia [NA]
Clinical trial update shows completion of a study investigating transcranial direct current stimulation for Primary Progressive Aphasia, wit…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)
An update on the LANDSCAPE clinical trial (sponsored by The Chinese University of Hong Kong) showing current enrollment by invitation to stu…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Long-term Effect of TMS in Primary Progressive Aphasia [NA]
This clinical trial update reports the completed long-term effects of transcranial magnetic stimulation (TMS) in primary progressive aphasia…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration
Completed clinical trial update examining social cognition and personality changes in Alzheimer's disease, Parkinson's disease, and frontote…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Proteinopathies Expression in Skin of Neurodegenerative Disorders
Clinical trial examining skin expression of proteinopathies in several neurodegenerative diseases; currently recruiting and led by Universid…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults [NA]
ClinicalTrials.gov entry reporting a study in recruitment evaluating transcranial alternating current stimulation with digital cognitive tra…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial of palmitoylethanolamide combined with luteoline for frontotemporal dementia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Dopaminergic Therapy for Frontotemporal Dementia Patients [Phase 2]
A Phase 2 clinical trial evaluating a dopaminergic therapy for frontotemporal dementia has completed; outcomes are not detailed in the snipp…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients [NA]
A clinical trial is recruiting to evaluate the effects of probiotics in patients within the amyotrophic lateral sclerosis-frontotemporal dem…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Gamma-Induction in FrontoTemporal Dementia Trial [NA]
An update on the Gamma-Induction in Frontotemporal Dementia clinical trial; the current status of the study is not provided. The trial is sp…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ADDIA Proof-of-Performance Clinical Study
ADDIA Proof-of-Performance clinical study by Amoneta Diagnostics SAS has completed; the update lists multiple neurodegenerative conditions a…